🚀 VC round data is live in beta, check it out!
Exact Sciences Valuation Multiples
Discover revenue and EBITDA valuation multiples for Exact Sciences and similar public comparables like Illumina, Quest Diagnostics, Labcorp, Hologic and more.
Exact Sciences Overview
About Exact Sciences
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Founded
1995
HQ
Employees
7.2K
Website
Financials (FY)
EV
$21B
Exact Sciences Stock Performance
Exact Sciences has current market cap of $20B, and enterprise value of $21B.
Market Cap Evolution
Exact Sciences' stock price is $103.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $21B | $20B | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialExact Sciences Valuation Multiples
Exact Sciences Financial Valuation Multiples
As of April 18, 2026, Exact Sciences has market cap of $20B and EV of $21B.
Equity research analysts estimate Exact Sciences' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $20B | XXX | $20B | XXX | XXX | XXX |
| EV (current) | $21B | XXX | $21B | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Exact Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Exact Sciences Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics and Diagnostics & Genomics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Exact Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Illumina | XXX | XXX | XXX | XXX | XXX | XXX |
| Quest Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Labcorp | XXX | XXX | XXX | XXX | XXX | XXX |
| Hologic | XXX | XXX | XXX | XXX | XXX | XXX |
| United Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Exact Sciences M&A Activity
Exact Sciences acquired XXX companies to date.
Last acquisition by Exact Sciences was on XXXXXXXX, XXXXX. Exact Sciences acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Exact Sciences
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialExact Sciences Investment Activity
Exact Sciences invested in XXX companies to date.
Exact Sciences made its latest investment on XXXXXXXX, XXXXX. Exact Sciences invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Exact Sciences
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Exact Sciences
| When was Exact Sciences founded? | Exact Sciences was founded in 1995. |
| Where is Exact Sciences headquartered? | Exact Sciences is headquartered in United States. |
| How many employees does Exact Sciences have? | As of today, Exact Sciences has over 7K employees. |
| Who is the CEO of Exact Sciences? | Exact Sciences' CEO is Kevin T. Conroy. |
| Is Exact Sciences publicly listed? | Yes, Exact Sciences is a public company listed on Moscow Exchange. |
| What is the stock symbol of Exact Sciences? | Exact Sciences trades under EXAS-RM ticker. |
| When did Exact Sciences go public? | Exact Sciences went public in 2001. |
| Who are competitors of Exact Sciences? | Exact Sciences main competitors are Illumina, Quest Diagnostics, Labcorp, Hologic. |
| What is the current market cap of Exact Sciences? | Exact Sciences' current market cap is $20B. |
| Is Exact Sciences profitable? | No, Exact Sciences is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.